INTERNATIONAL PATENT: ARGENX BV FILES APPLICATION FOR "METHODS FOR REDUCING PLATELET DEGRADATION USING FCRN ANTAGONISTS"

GENEVA, Nov. 3 -- ARGENX BV (Industriepark Zwijnaarde 79052 Ghent) filed a patent application (PCT/IB2025/000186) for "METHODS FOR REDUCING PLATELET DEGRADATION USING FCRN ANTAGONISTS" on Apr 22, 2025. With publication no. WO/2025/224506, the details related to the patent application was published on Oct 30, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): ULRICHTS, Peter (c/o Argenx BVIndustriepark Zwijnaarde 79052 Ghent), GODAR, Marie (c/o Argenx BVIndustriepark Zwijnaarde 79052 Ghent), HULTBERG, Anna (c/o Argenx BVIndustriepark Zwijnaarde 79052 Ghent), MATTHIJSSENS, Filip (c/o Argenx BVInd...